IDO1 and myocardial infarction: Regarding KYN biosynthesis with the help of IDO, KYN is markedly upregulated after myocardial infarction, and a genetic deletion or pharmacological inhibition of IDO attenuates cardiac damage and cardiac dysfunction after myocardial infarction [345].